About Benjamin Burley
Form D filings for VistaPath Biosystems from 2019 to 2023 list Benjamin Burley as executive officer and director.
Benjamin Burley first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Benjamin Burley in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Benjamin Burley works with at each company, as listed on that company's latest Form D.
VistaPath Biosystems, Inc. · Form D, Jul 7, 2023
TS
Timothy Spong
Chief Executive Officer and director